Will the results be positive?
Market price is near 0.483, which seems undervalued given a 60% intrinsic probability of a positive outcome. Buying yes shares appears attractive within the portfolio's max buy cap. Steady-state cap reduced request to $362.20.
The intrinsic probability of success is low, while the market prices it near 50/50. This presents a mispricing, offering an opportunity to sell YES shares at an inflated price. Steady-state cap reduced request to $0.00.
Intrinsic probability (35%) is slightly below market price (48.3%), suggesting a mild overvaluation. However, the gap is narrow and confidence is moderate. With no existing position, a trade would require conviction...
Market misprices NO at ~0.52. Eagle's near-bankruptcy and the suspension of the CAL02 trial due to weak interim data make a positive outcome highly improbable. Strong conviction to BUY_NO.
Intrinsic 40% YES < market 49%; NO underpriced by ~9%. Buy max allowed USD on moderate conf edge; no position, sells capped at 0.
